Month: May 2019

It’s been six months since Congress passed the Farm Bill legalizing hemp for cultivation. It’s high time that we rectify some common myths about this plant.Original Article

The human endocannabinoid system (ECS) is so named because it responds to cannabis compounds.

Original Article

In June 2018, the Food and Drug Administration (FDA) gave its blessing to “Epidiolex,” a purfied CBD pharmaceutical, for treating severe pediatric epilepsy. Six months later, Congress passed the Farm Bill, which legalized the cultivation of industrial hemp for many uses, including the production of biomass for CBD oil extraction.

Original Article

A new wave of research points toward cannabinoids having an adaptive, immunomodulating effect, rather than just suppressing immune activity.Original Article

The state of veterinary medicine has advanced significantly in recent years and thanks to the availability of more effective medicine, many pets are living longer than they would have years ago. With age however, comes the onset of problems such as arthritis and other forms of pain and inflammation. Conventional pharmaceuticals commonly used to treat pain sometimes have a negative impact on the immune system, GI tract, liver, and kidneys. Additionally, they don’t always work as well as we would like them to – for humans as well as our pets.1

Original Article

In this edition of Cannabis Conversations, Martin A. Lee speaks with Greg Gerdeman, neuroscientist, former professor, and chief science officer with 3 Boys Farms on the endocannabinoid system and the biology of wellness.

Original Article